erythrasma

AbbVie and Eisai Announce Fully Human Anti-TNF-alpha Monoclonal Antibody HUMIRA is the First in Japan to be Approved for the Treatment of Hidradenitis Suppurativa

New Delhi, February 22, 2019: (JCN Newswire) – AbbVie, a research-based global biopharmaceutical company and Eisai Co., Ltd. announced that they…

5 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420